Depo-Provera 2025 Lawsuits

Table of Contents

GlaxoSmithKline PLC has agreed to pay up to $2.2 billion to settle more than 90% of pending U.S. state court product liability cases involving Zantac. These lawsuits claim that a discontinued version of the heartburn medication contained NDMA, a probable human carcinogen, which led to cancer in numerous users.

This settlement marks a significant step in addressing the claims of individuals and families affected by Zantac-related health issues. If you believe Zantac may have impacted your health, now is the time to consult with experienced Zantac lawsuit attorneys to understand your legal options.

By clicking the ‘Get a Free Review’ button, I hereby grant consent to be contacted at the phone number above for marketing purposes by Tort Advisor and its partners. I understand this may include an automated calling system, artificial voice, pre-recorded message, or an SMS text message. I consent even if my phone number provided is registered on the Federal or State ‘Do Not Call Registry’. I acknowledge that standard message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to cancel. Clicking ‘Get a Free Review’ constitutes my electronic signature for authorization to be contacted and my agreement to the Terms and Conditions and [Privacy Policy]. This authorization is not required to qualify for, purchase goods, or receive services.

Partners Off-Canvas (Hidden)